To examine lung cancer screening (LCS) outcomes in people living with HIV (PLWH). Further, we aimed to understand perspectives of providers regarding LCS in PLWH to contextualize current screening outcomes and referrals. Phase 1 involved electronic health record review to identify PLWH who had undergone a shared decision-making visit and LCS from 2015 to 2023 at Medical University of South Carolina (MUSC). Inclusion criteria were consistent with LCS eligibility criteria plus HIV diagnosis. Shared decision making visits were completed by 61 PLWH. Phase 2 included a survey of infectious disease providers' ( N = 12) knowledge of and perceived barriers to LCS at MUSC. In Phase 1, 97% ( N = 59/61) completed baseline LCS. At baseline 58% had a normal lung RADS score. Two individuals were diagnosed with cancer (3%, N = 2/59). In Phase 2, twelve providers responded to the survey with 100% agreeing LCS is beneficial to PLWH. Majority of providers (83%) endorsed lack of knowledge on LCS guidelines. Among PLWH who completed a LCS, a clinically meaningful proportion had positive findings, including early-stage cancers. Findings from this study could be used to improve implementation of LCS programs in PLWH and programs to educate providers.
Hatch et al. (Wed,) studied this question.